23andMe Investor Presentation Deck

(in $M, except percentages) Consumer Services Research Services Therapeutics Total Revenue Revenue Composition Amount $56 8 $65 Three Months Ended June 30, FY2023 Percentage of Revenue 87% 13% 100% Amount $48 11 $59 FY2022 Percentage of Revenue 81% 19% 100% Year Ended March 31, Amount $222 50 $272 Copyright © 2022 23and Me, Inc. FY2022 Percentage of Revenue 82% 18% 100% 23andMe 50

View entire presentation